<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: toxic protein</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Doctor says, 'I think we're going to cure Alzheimer's disease, and we're not far away from it'</title>
   	 <description>Alzheimer's disease is on the rise, but researchers like Dr. Michael Devous expect the numbers to shift into reverse. &quot;I think we're going to cure Alzheimer's disease, and we're not far away from it,&quot; said Devous, a professor and director of the NeuroImaging Core for the Alzheimer's Disease Center at the University of Texas Southwestern Medical Center.</description>
	  <link>http://medicalxpress.com/news/2013-06-doctor-alzheimer-disease.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Fri, 07 Jun 2013 12:40:01 EST</pubDate>
	 <guid isPermaLink="false">news289823937</guid>
	 
</item>
<item>
     <title>Drug reverses Alzheimer's disease deficits in mice, research confirms</title>
   	 <description>An anti-cancer drug reverses memory deficits in an Alzheimer's disease mouse model, University of Pittsburgh Graduate School of Public Health researchers confirm in the journal Science.</description>
	  <link>http://medicalxpress.com/news/2013-05-drug-reverses-alzheimer-disease-deficits.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Thu, 23 May 2013 14:06:26 EST</pubDate>
	 <guid isPermaLink="false">news288536778</guid>
	 
</item>
<item>
     <title>Cancer drug prevents build-up of toxic brain protein</title>
   	 <description>Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson's disease in the brains of mice. This finding provides the basis to plan a clinical trial in humans to study the effects.</description>
	  <link>http://medicalxpress.com/news/2013-05-cancer-drug-build-up-toxic-brain.html</link>
	 <category>Genetics</category>
	 <pubDate>Fri, 10 May 2013 00:10:02 EST</pubDate>
	 <guid isPermaLink="false">news287338927</guid>
	 
</item>
<item>
     <title>Scientists much closer to developing screening test for early detection of Alzheimer's disease</title>
   	 <description>They identified blood-based biological markers that are associated with the build up of a toxic protein in the brain which occurs years before symptoms appear and irreversible brain damage has occurred.</description>
	  <link>http://medicalxpress.com/news/2013-05-scientists-closer-screening-early-alzheimer.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Wed, 01 May 2013 08:22:40 EST</pubDate>
	 <guid isPermaLink="false">news286615351</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/scientistsmu.jpg" width="90" height="90" />
</item>
<item>
     <title>More evidence berries have health-promoting properties</title>
   	 <description>Adding more color to your diet in the form of berries is encouraged by many nutrition experts. The protective effect of berries against inflammation has been documented in many studies. Diets supplemented with blueberries and strawberries have also been shown to improve behavior and cognitive functions in stressed young rats.</description>
	  <link>http://medicalxpress.com/news/2013-04-evidence-berries-health-promoting-properties.html</link>
	 <category>Health</category>
	 <pubDate>Sun, 21 Apr 2013 17:22:01 EST</pubDate>
	 <guid isPermaLink="false">news285783715</guid>
	 
</item>
<item>
     <title>Science surprise: Toxic protein made in unusual way may explain brain disorder</title>
   	 <description>A bizarre twist on the usual way proteins are made may explain mysterious symptoms in the grandparents of some children with mental disabilities.</description>
	  <link>http://medicalxpress.com/news/2013-04-science-toxic-protein-unusual-brain.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Thu, 18 Apr 2013 12:18:39 EST</pubDate>
	 <guid isPermaLink="false">news285506312</guid>
	 
</item>
<item>
     <title>Study confirms no transmission of Alzheimer's proteins between humans</title>
   	 <description>A new study found no evidence to support concerns that abnormal neurodegenerative disease proteins are &quot;infectious&quot; or transmitted from animals to humans or from one person to another.</description>
	  <link>http://medicalxpress.com/news/2013-02-transmission-alzheimer-proteins-humans.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Mon, 04 Feb 2013 16:00:03 EST</pubDate>
	 <guid isPermaLink="false">news279198034</guid>
	 
</item>
<item>
     <title>New understanding can lead to srategies for dealing with neurodegenerative diseases</title>
   	 <description>A new understanding of what takes place on the cellular level during the development of neurodegenerative diseases, such as Parkinson's, Alzheimer's, ALS and Huntington's diseases, offers promise towards possible new strategies for combating such diseases, say Hebrew University of Jerusalem researchers.</description>
	  <link>http://medicalxpress.com/news/2012-12-srategies-neurodegenerative-diseases.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 06 Dec 2012 10:44:36 EST</pubDate>
	 <guid isPermaLink="false">news274013065</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/2-newunderstan.jpg" width="90" height="84" />
</item>
<item>
     <title>Novel antibodies for combating Alzheimer's and Parkinson's disease</title>
   	 <description>Antibodies developed by researchers at Rensselaer Polytechnic Institute are unusually effective at preventing the formation of toxic protein particles linked to Alzheimer's disease and Parkinson's disease, as well as Type 2 diabetes, according to a new study.</description>
	  <link>http://medicalxpress.com/news/2012-12-antibodies-combating-alzheimer-parkinson-disease.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 03 Dec 2012 12:51:26 EST</pubDate>
	 <guid isPermaLink="false">news273761473</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/novelantibod.jpg" width="90" height="90" />
</item>
<item>
     <title>Genome-scale study identifies hundreds of potential drug targets for Huntington's disease</title>
   	 <description>Scientists searching for ways to develop treatments for Huntington's disease (HD) just got a roadmap that could dramatically speed their discovery process. Researchers at the Buck Institute have used RNA interference (RNAi) technology to identify hundreds of &quot;druggable&quot; molecular targets linked to the toxicity associated with the devastating, ultimately fatal disease. The results from this unprecedented genome-scale screen in a human cell model of HD are published in the November 29, 2012 edition of PLOS Genetics. The work was is a collaboration between Buck Institute faculty members Robert E. Hughes, Ph.D., Sean Mooney, Ph.D., Lisa Ellerby, Ph.D. and Juan Botas, Ph.D. at the Baylor College of Medicine.</description>
	  <link>http://medicalxpress.com/news/2012-11-genome-scale-hundreds-potential-drug-huntington.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 29 Nov 2012 17:32:16 EST</pubDate>
	 <guid isPermaLink="false">news273432726</guid>
	 
</item>
<item>
     <title>Researchers report potential new treatment to stop Alzheimer's disease</title>
   	 <description>Last March, researchers at UCLA reported the development of a molecular compound called CLR01 that prevented toxic proteins associated with Parkinson's disease from binding together and killing the brain's neurons.</description>
	  <link>http://medicalxpress.com/news/2012-11-potential-treatment-alzheimer-disease.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Thu, 15 Nov 2012 15:23:42 EST</pubDate>
	 <guid isPermaLink="false">news272215411</guid>
	 
</item>
<item>
     <title>Researchers identify new enzyme to fight Alzheimer's disease</title>
   	 <description>An enzyme that could represent a powerful new tool for combating Alzheimer's disease has been discovered by researchers at Mayo Clinic in Florida. The enzyme—known as BACE2—destroys beta-amyloid, a toxic protein fragment that litters the brains of patients who have the disease. The findings were published online Sept. 17 in the science journal Molecular Neurodegeneration.</description>
	  <link>http://medicalxpress.com/news/2012-09-enzyme-alzheimer-disease.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Mon, 17 Sep 2012 16:18:17 EST</pubDate>
	 <guid isPermaLink="false">news267117401</guid>
	 
</item>
<item>
     <title>Toxic protein build-up in blood shines light on Huntington's disease</title>
   	 <description>A new light-based technique for measuring levels of the toxic protein that causes Huntington's disease (HD) has been used to demonstrate that the protein builds up gradually in blood cells. Published today in the Journal of Clinical Investigation, the findings shed light on how the protein causes damage in the brain, and could be useful for monitoring the progression of HD, or testing new drugs aimed at suppressing production of the harmful protein.</description>
	  <link>http://medicalxpress.com/news/2012-09-toxic-protein-build-up-blood-huntington.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 17 Sep 2012 12:00:07 EST</pubDate>
	 <guid isPermaLink="false">news267096211</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/65edyjtdj.jpg" width="90" height="90" />
</item>
<item>
     <title>Proposed drug may reverse Huntington's disease symptoms</title>
   	 <description>With a single drug treatment, researchers at the Ludwig Institute for Cancer Research at the University of California, San Diego School of Medicine can silence the mutated gene responsible for Huntington's disease, slowing and partially reversing progression of the fatal neurodegenerative disorder in animal models.</description>
	  <link>http://medicalxpress.com/news/2012-06-drug-reverse-huntington-disease-symptoms.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 20 Jun 2012 12:00:01 EST</pubDate>
	 <guid isPermaLink="false">news259411330</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/proposeddrug.jpg" width="90" height="90" />
</item>
<item>
     <title>Vaccine trial for Alzheimer's clears key hurdle</title>
   	 <description> A vaccine which revives a promising but long-abandoned path to thwart Alzheimer's disease has cleared a key safety hurdle in human trials, researchers say.</description>
	  <link>http://medicalxpress.com/news/2012-06-vaccine-trial-alzheimer-key-hurdle.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Thu, 07 Jun 2012 09:18:17 EST</pubDate>
	 <guid isPermaLink="false">news258279486</guid>
	 
</item>
<item>
     <title>Transneuronal spread model fits neurodegenerative disease</title>
   	 <description>(HealthDay) -- Neurodegenerative diseases may be characterized by specific regions of the brain that are critical network epicenters, with disease-related vulnerability associated with shorter paths to the epicenter and greater total connectional flow, according to a study published in the March 22 issue of Neuron.</description>
	  <link>http://medicalxpress.com/news/2012-03-transneuronal-neurodegenerative-disease.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Sat, 24 Mar 2012 06:47:54 EST</pubDate>
	 <guid isPermaLink="false">news251790425</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/transneurona.jpg" width="90" height="90" />
</item>
<item>
     <title>Computer model of spread of dementia can predict future disease patterns years before they occur</title>
   	 <description>Researchers at Weill Cornell Medical College have developed a computer program that has tracked the manner in which different forms of dementia spread within a human brain. They say their mathematic model can be used to predict where and approximately when an individual patient's brain will suffer from the spread, neuron to neuron, of &quot;prion-like&quot; toxic proteins -- a process they say underlies all forms of dementia.</description>
	  <link>http://medicalxpress.com/news/2012-03-dementia-future-disease-patterns-years.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 21 Mar 2012 14:42:28 EST</pubDate>
	 <guid isPermaLink="false">news251559739</guid>
	 
</item>
<item>
     <title>Traitor proteins that could attack the body widespread, researchers find</title>
   	 <description>(Medical Xpress) -- More than 32 million Americans harbor potentially toxic proteins that can attack body tissues and lead to autoimmune diseases such as lupus and scleroderma, according to a new University of Florida study.</description>
	  <link>http://medicalxpress.com/news/2012-03-traitor-proteins-body-widespread.html</link>
	 <category>Immunology</category>
	 <pubDate>Fri, 02 Mar 2012 06:05:20 EST</pubDate>
	 <guid isPermaLink="false">news249890705</guid>
	 
</item>
<item>
     <title>A natural dye obtained from lichens may combat Alzheimer's disease</title>
   	 <description>A red dye derived from lichens that has been used for centuries to color fabrics and food appears to reduce the abundance of small toxic protein aggregates in Alzheimer's disease. The dye, a compound called orcein, and a related substance, called O4, bind preferentially to small amyloid aggregates that are considered to be toxic and cause neuronal dysfunction and memory impairment in Alzheimer's disease. </description>
	  <link>http://medicalxpress.com/news/2011-12-natural-dye-lichens-combat-alzheimer.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 02 Dec 2011 10:20:03 EST</pubDate>
	 <guid isPermaLink="false">news242042259</guid>
	 
</item>
<item>
     <title>Poor recycling of BACE1 enzyme could promote Alzheimer's disease</title>
   	 <description>Sluggish recycling of a protein-slicing enzyme could promote Alzheimer's disease, according to a study published online on November 21 in The Journal of Cell Biology.</description>
	  <link>http://medicalxpress.com/news/2011-11-poor-recycling-bace1-enzyme-alzheimer.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 21 Nov 2011 12:00:03 EST</pubDate>
	 <guid isPermaLink="false">news241097829</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/poorrecyclin.jpg" width="90" height="90" />
</item>
<item>
     <title>Treatment with vitamin C dissolves toxic protein aggregates in Alzheimer's disease</title>
   	 <description>Researchers at Lund University have discovered a new function for vitamin C. Treatment with vitamin C can dissolve the toxic protein aggregates that build up in the brain in Alzheimer's disease. The research findings are now being presented in the Journal of Biological Chemistry.</description>
	  <link>http://medicalxpress.com/news/2011-08-treatment-vitamin-dissolves-toxic-protein.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 18 Aug 2011 10:33:40 EST</pubDate>
	 <guid isPermaLink="false">news232882391</guid>
	 
</item>
<item>
     <title>Pilot study suggests new approach to treat preeclampsia</title>
   	 <description>A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition &amp;#150; balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.  In a paper receiving online release in the journal Circulation, a team of U.S. and German researchers report promising results from their pilot study of a filtration technology that reduces reduce excess blood levels of soluble Flt-1, a protein that limits the growth of blood vessels, in women with very preterm preeclampsia.</description>
	  <link>http://medicalxpress.com/news/2011-08-approach-preeclampsia.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 02 Aug 2011 12:40:04 EST</pubDate>
	 <guid isPermaLink="false">news231505358</guid>
	 
</item>
<item>
     <title>Lithium profoundly prevents brain damage associated with Parkinson's disease</title>
   	 <description>Lithium profoundly prevents the aggregation of toxic proteins and cell loss associated with Parkinson's disease (PD) in a mouse model of the condition.</description>
	  <link>http://medicalxpress.com/news/2011-06-lithium-profoundly-brain-parkinson-disease.html</link>
	 <category>Parkinson's &amp; Movement disorders</category>
	 <pubDate>Fri, 24 Jun 2011 04:14:26 EST</pubDate>
	 <guid isPermaLink="false">news228107624</guid>
	 
</item>
<item>
     <title>Researchers find new clues about aging</title>
   	 <description>National Institutes of Health researchers have identified a new pathway that sets the clock for programmed aging in normal cells. The study provides insights about the interaction between a toxic protein called progerin and telomeres, which cap the ends of chromosomes like aglets, the plastic tips that bind the ends of shoelaces.</description>
	  <link>http://medicalxpress.com/news/2011-06-nih-clues-aging.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 13 Jun 2011 12:57:35 EST</pubDate>
	 <guid isPermaLink="false">news227188620</guid>
	 
</item>


</channel>
</rss>
